{
    "Trade/Device Name(s)": [
        "BD ProbeTec Neisseria gonorrhoeae (GC) Qx Amplified DNA Assay"
    ],
    "Submitter Information": "BD Diagnostic Systems",
    "510(k) Number": "K091724",
    "Predicate Device Reference 510(k) Number(s)": [
        "K081825",
        "K062440"
    ],
    "Regulatory Class": "Class II",
    "Product Code(s)": [
        "LSL"
    ],
    "Summary Letter Date": "November 13, 2009",
    "Summary Letter Received Date": "June 11, 2009",
    "Submission Date": "June 10, 2009",
    "Regulation Number(s)": [
        "21CFR866.3390"
    ],
    "Regulation Name(s)": [
        "Neisseria spp. direct serological test reagents"
    ],
    "Analyte Class(es)": [
        "microbiology",
        "virology"
    ],
    "Analyte(s)": [
        "Neisseria gonorrhoeae DNA"
    ],
    "Specimen Type(s)": [
        "Clinician-collected female endocervical swab",
        "Clinician-collected male urethral swab",
        "Patient-collected vaginal swab (in clinical setting)",
        "Male urine",
        "Female urine",
        "Gynecological specimens collected in BD SurePath Preservative Fluid"
    ],
    "Specimen Container(s)": [
        "Swab",
        "Urine cup",
        "BD SurePath Preservative Fluid",
        "LBC Specimen Dilution Tubes"
    ],
    "Instrument(s)/Platform(s)": [
        "BD Viper System"
    ],
    "Method(s)/Technology(ies)": [
        "Strand Displacement Amplification (SDA)",
        "Fluorescent probe detection"
    ],
    "Methodologies": [
        "DNA amplification",
        "Qualitative nucleic acid detection"
    ],
    "Submission Type(s)": [
        "Assay",
        "Reagent"
    ],
    "Document Summary": "FDA 510(k) summary for BD ProbeTec Neisseria gonorrhoeae (GC) Qx Amplified DNA Assay using SDA technology on the BD Viper System for direct qualitative detection of Neisseria gonorrhoeae DNA",
    "Indications for Use Summary": "Qualitative detection of Neisseria gonorrhoeae DNA in swabs, urine, and gynecological specimens with the BD Viper System to aid in the diagnosis of gonococcal urogenital disease in symptomatic and asymptomatic individuals",
    "fda_folder": "Microbiology"
}